NS-863
/ Nippon Shinyaku
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 28, 2026
A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
(clinicaltrials.gov)
- P2 | N=177 | Not yet recruiting | Sponsor: NS Pharma, Inc.
New P2 trial • Cardiovascular • Hypertension • Interstitial Lung Disease • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases
February 28, 2026
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
(clinicaltrials.gov)
- P2 | N=135 | Not yet recruiting | Sponsor: NS Pharma, Inc.
New P2 trial • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1